Cargando…

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma

Metabolic reprogramming is closely related to melanoma. However, the prognostic role of metabolism-related genes (MRGs) remains to be elucidated. We aimed to establish a nomogram by combining MRGs signature and clinicopathological factors to predict melanoma prognosis. Eighteen prognostic MRGs betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Furong, Su, Juan, Peng, Cong, Liao, Mengting, Zhao, Shuang, Guo, Ying, Chen, Xiang, Deng, Guangtong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509113/ https://www.ncbi.nlm.nih.gov/pubmed/33014847 http://dx.doi.org/10.3389/fonc.2020.01710

Ejemplares similares

A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients
por: Liao, Mengting, et al.
Publicado: (2020)

Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma
por: Luo, Huan, et al.
Publicado: (2020)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
por: Xing, Jiahua, et al.
Publicado: (2022)

Metabolic Traits in Cutaneous Melanoma
por: Neagu, Monica
Publicado: (2020)

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022)

Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016)

Immune-related risk score: An immune-cell-pair-based prognostic model for cutaneous melanoma
por: Li, Mingjia, et al.
Publicado: (2023)

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway
por: Deng, Guangtong, et al.
Publicado: (2020)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021)

Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma
por: Mu, Teng, et al.
Publicado: (2022)

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021)

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
por: Zhao, Xiaobei, et al.
Publicado: (2019)

EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma
por: Deng, Guangtong, et al.
Publicado: (2022)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment
por: Nurzat, Yeltai, et al.
Publicado: (2021)

Nomogram based on autophagy related genes for predicting the survival in melanoma
por: Deng, Guangtong, et al.
Publicado: (2021)

Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma
por: Song, Binyu, et al.
Publicado: (2022)

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021)

Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
por: Nurzat, Yeltai, et al.
Publicado: (2023)

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma
por: Xie, Yalin, et al.
Publicado: (2022)

Pyroptosis-Related Gene Signatures Can Robustly Diagnose Skin Cutaneous Melanoma and Predict the Prognosis
por: Ju, Anji, et al.
Publicado: (2021)

New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
por: Zhou, Sitong, et al.
Publicado: (2021)

Construction of a prognostic signature for serous ovarian cancer based on lactate metabolism-related genes
por: Xiang, Jiangdong, et al.
Publicado: (2022)

eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma
por: Zhang, Fangyingnan, et al.
Publicado: (2022)

ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
por: Deng, TengFei, et al.
Publicado: (2023)

A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables
por: Tang, Yifan, et al.
Publicado: (2022)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma
por: Tong, Xiaoxia, et al.
Publicado: (2021)

Laparoscopic versus open gastrectomy for gastric cancer
por: Zeng, Furong, et al.
Publicado: (2020)

Ferroptosis-Associated Classifier and Indicator for Prognostic Prediction in Cutaneous Melanoma
por: Zeng, Hao, et al.
Publicado: (2021)

Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming
por: Zuo, Sipeng, et al.
Publicado: (2022)

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
por: Zeng, Furong, et al.
Publicado: (2023)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
por: Zeng, Furong, et al.
Publicado: (2022)

Association of JAK/STAT genetic variants with cutaneous melanoma
por: Gomez, Gabriela Vilas Bôas, et al.
Publicado: (2022)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma
por: Takabe, Piia, et al.
Publicado: (2022)

Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
por: Meng, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dj10oo05dssqn5phllga2f78ge